LAWSUITS NEWS & LEGAL INFORMATION
Hair Straightener Cancer
By Jane Mundy
Recent studies have found that hair straighteners and hair relaxers contain toxic chemicals that are known to cause cancer. Increasingly, women who frequently used these products and have been diagnosed with uterine cancer or breast cancer are filing hair straightener cancer lawsuits against L’Oreal, Revlon, and other manufacturers. As well, women who developed uterine fibroids and underwent surgical removal or a hysterectomy are also filing hair relaxer lawsuits.
According to hair straightener lawsuits, cosmetics companies knew their products were harmful since at least 2015 but withheld toxic chemicals from ingredient labels and failed to warn consumers of the health risks. For decades, manufacturers aggressively marketed and promoted hair relaxer or straightener products mainly to Black consumers (some of whom used hair relaxers for decades) as safe, and these products generated billions of dollars in sales.
The NIH researchers determined that women who reported frequent use of hair straightening products were more than twice as likely to go on to develop uterine cancer compared to those who did not use the products. About 60 percent of the participants who reported using straighteners in the previous year were self-identified Black women, according to the study also published in the Journal of the National Cancer Institute.
The same researchers at NIH also found that that permanent hair dye and straighteners may increase breast and ovarian cancer risk. The International Journal of Cancer, which published a study in December 2019, suggests that breast cancer risk increased with more frequent use of these chemical hair products.
The above chemicals are known as endocrine disruptors (EDCs). These endocrine disrupting chemicals are known to disrupt the natural production of hormones and they can cause cancer cells to grow more rapidly, particularly when associated with the female reproductive system, hence higher risk of uterine cancer and breast cancer.
In a study published by the Journal of Health and Pollution (JHP) in May 2021, researchers found excessive levels of parabens and phthalates in urine samples that were associated with a significantly higher risk of developing endometrial cancer. They noted that women were at the highest risk due to the ability of these chemicals to alter the function of proteins and cells found inside of the female reproductive system, as well as disrupt the body’s normal regulation of hormones.
Under the FD&C Act, companies cannot market products that are “adulterated” or “misbranded.” Adulterated products are defined as those with substances that cause injury to the user or are contained in a manner that makes the product harmful to health. Misbranded products include those that have been improperly labeled or deceptively packaged. It is illegal for companies to put harmful ingredients, such as chemicals known to be associated with cancer, in their products.
The Fair Packaging and Labeling Act of 1966 is consumer protection legislation. The act directs the FDA and the Federal Trade Commission to regulate product manufacturers’ truthful disclosure of information on labels and packages, including the contents, commodity, and name and place of businesses of the product’s manufacturer, packer, or distributor.
The Environmental Protection Agency (EPA) announced early February 2023 that it plans to start regulating phthalates like Diisononyl Phthalate (DINP) as toxic chemicals subject to reporting requirements.
Here are a few excerpts from her 77-page complaint:
The first hair relaxer lawsuit involving uterine fibroids was filed last December in the Southern District of Georgia (Gamble v. Strength of Nature Global, LLC, et al. (4:22-cv-00256). The plaintiff claims she used hair relaxer products from the age of six and developed uterine fibroids when she was 22 years old.
A group of hair relaxer plaintiffs filed a motion with the JPML requesting consolidation of all hair relaxer product liability cases in federal courts into a new class action MDL. The defendants, led by L’Oreal, filed a response opposing the request for consolidation, preferring the Southern District of New York. However, on February 6, 2023, the JPML issued an Order consolidating all hair relaxer cancer lawsuits in federal courts into in the Northern District of Illinois in Chicago. The MDL will begin with approximately 60 pending cases from districts across the U.S.
Hair Relaxer Uterine Cancer lawsuits have been filed against the following companies:
Published on Mar-1-23
FREE HAIR STRAIGHTENER LAWSUIT EVALUATION
Send your HAIR STRAIGHTENER claim to a lawyer who will review your claim at NO COST or obligation.
GET LEGAL HELP NOW
GET LEGAL HELP NOW
Research and Studies
The Sister Study, published in October 2022 by the National Institute of Environmental Health (NIEHS, which is part of NIH), found that women who regularly (at least every five to eight weeks) used hair relaxer products had a 156 percent increased risk of uterine cancer and 30 percent increased risk of breast cancer. The Sister Study followed 33,947 women aged 35 to 74 for a period of 11 years.The NIH researchers determined that women who reported frequent use of hair straightening products were more than twice as likely to go on to develop uterine cancer compared to those who did not use the products. About 60 percent of the participants who reported using straighteners in the previous year were self-identified Black women, according to the study also published in the Journal of the National Cancer Institute.
The same researchers at NIH also found that that permanent hair dye and straighteners may increase breast and ovarian cancer risk. The International Journal of Cancer, which published a study in December 2019, suggests that breast cancer risk increased with more frequent use of these chemical hair products.
Hair Relaxer Carcinogenic Chemicals
The scientists noted that several chemicals linked to cancer are found in the hair straighteners, namely parabens, bisphenol A, metals, and formaldehyde. Exposure to these chemicals could be more worrisome than other personal care products due to increased absorption through the scalp, which may be exacerbated by burns and lesions caused by straighteners. As well, blood vessels in the scalp are closer to the surface of the skin than the rest of the body, which makes it easier for chemicals to be absorbed.The above chemicals are known as endocrine disruptors (EDCs). These endocrine disrupting chemicals are known to disrupt the natural production of hormones and they can cause cancer cells to grow more rapidly, particularly when associated with the female reproductive system, hence higher risk of uterine cancer and breast cancer.
In a study published by the Journal of Health and Pollution (JHP) in May 2021, researchers found excessive levels of parabens and phthalates in urine samples that were associated with a significantly higher risk of developing endometrial cancer. They noted that women were at the highest risk due to the ability of these chemicals to alter the function of proteins and cells found inside of the female reproductive system, as well as disrupt the body’s normal regulation of hormones.
Hair Straighteners and Relaxers and the FDA
Because chemical hair relaxants and straighteners are categorized as cosmetics, companies do not have to submit safety data to the FDA for approval before they go to market. However, the Federal Food Drug and Cosmetic Act (FD&C Act) and Fair Packaging and Labeling Act (FPLA) have laws that apply to cosmetic products sold in the U.S.Under the FD&C Act, companies cannot market products that are “adulterated” or “misbranded.” Adulterated products are defined as those with substances that cause injury to the user or are contained in a manner that makes the product harmful to health. Misbranded products include those that have been improperly labeled or deceptively packaged. It is illegal for companies to put harmful ingredients, such as chemicals known to be associated with cancer, in their products.
The Fair Packaging and Labeling Act of 1966 is consumer protection legislation. The act directs the FDA and the Federal Trade Commission to regulate product manufacturers’ truthful disclosure of information on labels and packages, including the contents, commodity, and name and place of businesses of the product’s manufacturer, packer, or distributor.
The Environmental Protection Agency (EPA) announced early February 2023 that it plans to start regulating phthalates like Diisononyl Phthalate (DINP) as toxic chemicals subject to reporting requirements.
Hair Relaxer and Straightener Litigation
Just one week after the above NIH study was published, the first hair straightener lawsuit was filed by Jenny Mitchell against L’Oreal and Namaste. The Missouri woman, age 32, was diagnosed with uterine cancer in 2018 and underwent a hysterectomy. She alleges her diagnosis was 'caused by regular and prolonged exposure to phthalates and other endocrine disrupting chemicals' found in L'Oreal products. Mitchell started using EDCs and/or phthalate-based products around 2000, when she was 10 years old.Here are a few excerpts from her 77-page complaint:
- [L’Oreal and other] companies allegedly knew their products were harmful since at least 2015 but failed to warn consumers of the health risks.
- “In the 1970s, lye relaxer users and manufacturers noticed that the lye formula stripped proteins from the hair strand, resulting in the hair thinning and breaking. As a result, Johnson and Johnson marketed the first ‘gentle’ hair relaxer in 1981, which used milder chemicals such as potassium hydroxide and lithium hydroxide.”
- “Defendants market their hair relaxer products to African American customers across the United States, and the world, reinforcing the same historical Eurocentric standards of beauty. Defendant’s marketing scheme relies heavily relying on branding and slogans that reinforce straight hair as the standard.”
- “Ms. Mitchell used Defendants’ Products by applying this to her scalp or by having a professional at a hair salon apply Defendants’ Products exactly as instructed by Defendants.”
- [Had Mitchell] received a warning that the use of the Products would significantly increase her risk of developing uterine cancer, she would not have used them. As a proximate result of Defendants’ design, manufacture, marketing, sale, and distribution of the Products, Plaintiff was injured catastrophically, and was caused severe pain, suffering, infertility, disability, impairment, loss of enjoyment of life, loss of care, comfort, and economic damages.”
The first hair relaxer lawsuit involving uterine fibroids was filed last December in the Southern District of Georgia (Gamble v. Strength of Nature Global, LLC, et al. (4:22-cv-00256). The plaintiff claims she used hair relaxer products from the age of six and developed uterine fibroids when she was 22 years old.
A group of hair relaxer plaintiffs filed a motion with the JPML requesting consolidation of all hair relaxer product liability cases in federal courts into a new class action MDL. The defendants, led by L’Oreal, filed a response opposing the request for consolidation, preferring the Southern District of New York. However, on February 6, 2023, the JPML issued an Order consolidating all hair relaxer cancer lawsuits in federal courts into in the Northern District of Illinois in Chicago. The MDL will begin with approximately 60 pending cases from districts across the U.S.
Hair Relaxer Uterine Cancer lawsuits have been filed against the following companies:
- L’Oreal (SoftSheen Carson)
- Revlon
- Strength of Nature Global, LLC
- Namaste Laboratories, LLC
- Godrej Global
- Dabur Ltd
HAIR STRAIGHTENER CANCER Legal Help
If you or a loved one has suffered similar damages or injuries, please fill in our form and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.Published on Mar-1-23
HAIR STRAIGHTENER LEGAL ARTICLES AND INTERVIEWS
Hair Relaxer Cancer Litigation Ongoing and Advocates Fight for Change
More Hair Relaxer Lawsuits Filed, Still Contain Formaldehyde
Lawmakers Pressure FDA to Ban Formaldehyde in Hair Relaxers
November 19, 2024
As advocates and watchdogs with organizations like the NAACP and the Environmental Working Group, and at least one politician, create more awareness amongst Black women about serious health risks of hair straightener products, more hair relaxer lawsuits are filed. And they are insisting that the regulatory framework needs to change. READ MORE
More Hair Relaxer Lawsuits Filed, Still Contain Formaldehyde
October 31, 2024
Just five months after a study published in 2021 showed a link between the use of hair straightener, women—and mostly Black women—diagnosed with uterine and ovarian cancers began filing hair relaxer lawsuits. By 2023, the FDA proposed a ban on formaldehyde and formaldehyde-releasing chemicals in the hair products, with an April 2024 deadline. Incredibly, April came and went and formaldehyde stayed. And the lawsuits are increasing. This October alone, 200 new cases joined the hair relaxer class action lawsuit. READ MORE
Lawmakers Pressure FDA to Ban Formaldehyde in Hair Relaxers
September 10, 2024
Two lawmakers in March 2023 wrote a letter to the FDA, urging it to ban harmful chemicals in hair relaxers. Last month, those lawmakers sent another letter to the agency asking why the proposed ban is still not in place. If not in place this month, the FDA will have missed its date three times. The FDA has already missed two of its hair relaxer formaldehyde bans, and one lawmaker believes another delay could cause more health issues for communities of color. READ MORE
READ MORE Defective Products Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News
READER COMMENTS
Juanita Webster
on
Azza aboukaram
on
Kassy lillard
on
Tammy a Monroe
on
L’Oreal (SoftSheen Carson)
Revlon
Strength of Nature Global, LLC
Namaste Laboratories, LLC
Godrej Global
Dabur Ltd
Vanessia Freeman